Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Published Date: 24 Jun 2026

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Three out of ten breast cancers detected between screenings, study finds

2.

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

3.

Where Did This Very Painful Gluteal Mass Come From?

4.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

5.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot